Impact of COVID19 Outbreak in Cardiac Acute Care

Heart Failure Clinical Trial

— CCU-COVID19  

Official title:

Impact of COVID19 Outbreak in Cardiac Patients Admitted in Intensive Care Unit : the CCU-COVID19 Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04344912
• Other study ID #: APHP200524
• Secondary ID: 0522070420
• Status: Recruiting
• Start date: March 20, 2020
• Est. completion date: August 2020

Study information

• Verified date: April 2020
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Johanne SILVAIN, MD PhD
• Phone: +33142162961
• Email: johanne.silvain[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This registry will evaluate the impact of the COVID19 outbreak on Cardiac patients admitted in the Intensive Care Unit of the Pitie-Salpetriere Hospital in Paris, France

Description:

Registry on Characteristics and outcomes of Cardiac patients (COVID- and COVID+) hospitalized in the Intensive Care Unit of the Pitie-Salpetriere Hospital in Paris, France

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: August 2020
• Est. primary completion date: June 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years and older

• Admitted in the Cardiac Intensive Care Unit from March 20th 2020

• Patient informed and having expressed his non-opposition to participate in the research

Exclusion Criteria:

• Minor patient

• Patient who expressed opposition to participation in the study

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• COVID
• Heart Failure

Intervention

Other:
• Data collection
Diagnostic and prognostic evaluation of cardiac patients hospitalized in CCU during the COVID-19 outbreak; patient's immune status regarding the presence of SARS-CoV-2 specific antibodies

Locations

Country	Name	City	State
France	Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP	Paris

Sponsors (2)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris	Action, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of recurrent Major Cardiovascular Events (MACE) and urgent rehospitalization		From admission to one year follow up